PLSE

Pulse Biosciences Inc

PLSE, USA

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; CellFX nsPFA Percutaneous Electrode system for soft tissue ablation in surgical setting; CellFX nsPFA Cardiac Clamp designed for use in surgical treatment of atrial fibrillation (AF); CellFX nsPFA 360° Cardiac Catheter designed to provide a circumferential, or circular, ablation in a single treatment cycle; and The CellFX Consol, a tunable, software-enabled, and console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.

https://www.pulsebiosciences.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
PLSE
stock
PLSE

How (PLSE) Movements Inform Risk Allocation Models news.stocktradersdaily.com

Read more →
PLSE
stock
PLSE

Pulse Biosciences (NASDAQ:PLSE) Trading Up 5% - Here's What Happened MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$22

Analyst Picks

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Neutral

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

10.35

Low 1

High 3

Return on Equity (ROE)

-

Very Low

-20.91 %

Low 5%

High 25%

Return on Assets (ROA)

-

Very Low

-17.82 %

Low 2%

High 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-15,233.72 %

Low 5%

High 15%

Debt to Equity

-

Very High

0.17

Low 1

High 0.3

Investors

* Institutions hold a combined 11.63% of the total shares of Pulse Biosciences Inc

1.

BlackRock Inc

(1.9976%)

since

2025/06/30

2.

Vanguard Group Inc

(1.8185%)

since

2025/06/30

3.

Bank of America Corp

(1.1643%)

since

2025/06/30

4.

Vanguard Total Stock Mkt Idx Inv

(0.8962%)

since

2025/07/31

5.

Geode Capital Management, LLC

(0.7422%)

since

2025/06/30

6.

iShares Russell 2000 ETF

(0.6454%)

since

2025/08/31

7.

State Street Corp

(0.623%)

since

2025/06/30

8.

Hovey Youngman Associates Inc

(0.3413%)

since

2025/06/30

9.

Vanguard Institutional Extnd Mkt Idx Tr

(0.3272%)

since

2025/07/31

10.

Northern Trust Corp

(0.2934%)

since

2025/06/30

11.

Fidelity Small Cap Index

(0.2651%)

since

2025/06/30

12.

Charles Schwab Investment Management Inc

(0.2562%)

since

2025/06/30

13.

iShares Russell 2000 Growth ETF

(0.2393%)

since

2025/08/31

14.

Fidelity Extended Market Index

(0.1624%)

since

2025/07/31

15.

Schwab US Small-Cap ETF™

(0.1462%)

since

2025/08/30

16.

Morgan Stanley - Brokerage Accounts

(0.1422%)

since

2025/06/30

17.

Vanguard Russell 2000 ETF

(0.1254%)

since

2025/07/31

18.

Westside Investment Management, Inc.

(0.0955%)

since

2025/06/30

19.

State St Russell Sm Cap® Indx SL Cl I

(0.0911%)

since

2025/08/31

20.

Vanguard US Momentum Factor ETF

(0.0873%)

since

2025/06/30

21.

Vanguard Health Care ETF

(0.0772%)

since

2025/07/31

22.

Pandora Wealth, Inc.

(0.0765%)

since

2025/06/30

23.

UBS Group AG

(0.0745%)

since

2025/06/30

24.

UBS Asset Mgmt Americas Inc

(0.0718%)

since

2025/06/30

25.

Nuveen, LLC

(0.0716%)

since

2025/06/30

26.

Schwab Small Cap Index

(0.0665%)

since

2025/07/31

27.

NT R2000 Index Fund - NL

(0.0647%)

since

2025/06/30

28.

Fidelity Nasdaq Composite Index

(0.0601%)

since

2025/07/31

29.

Bank of New York Mellon Corp

(0.0598%)

since

2025/06/30

30.

iShares Micro-Cap ETF

(0.0594%)

since

2025/08/31

31.

Extended Equity Market Fund K

(0.0559%)

since

2025/06/30

32.

Fidelity Total Market Index

(0.0554%)

since

2025/07/31

33.

iShares Core S&P Total US Stock Mkt ETF

(0.0544%)

since

2025/08/31

34.

NT R2000 Index Fund - DC - NL - 3

(0.0516%)

since

2025/06/30

35.

Barclays PLC

(0.0515%)

since

2025/06/30

36.

Swiss National Bank

(0.0477%)

since

2025/06/30

37.

Russell 2500™ Index Fund F

(0.0472%)

since

2025/06/30

38.

XTX Topco Ltd

(0.0459%)

since

2025/06/30

39.

TIAA Trust National Association

(0.0406%)

since

2025/06/30

40.

Rhumbline Advisers

(0.0402%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

EPS Estimate

Latest Release

Date

2025-09-30

EPS Actual

-0.29

EPS Estimate

-0.31

EPS Difference

0.02

Surprise Percent

6.4516%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(3)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.8)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(0.5)
Momentum
Moderate Momentum(3.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Low Quality Business(2.5)
Value
Overpriced(3)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.